Download PDF
Int J Sports Med 2013; 34(05): 402-408
DOI: 10.1055/s-0032-1323820
Physiology & Biochemistry
© Georg Thieme Verlag KG Stuttgart · New York

ACE Activity and Endurance Performance during the South African Ironman Triathlons

R. Domingo
1   Division of Medical Biochemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
,
E. D. Sturrock
1   Division of Medical Biochemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
,
M. Collins
2   Research Unit for Exercise Science and Sports Medicine, South African Medical Research Council, Cape Town, South Africa
3   Department of Human Biology, University of Cape Town, Cape Town, South Africa
› Author Affiliations
Further Information

Publication History



accepted after revision 16 August 2012

Publication Date:
22 October 2012 (online)

Also available at
    Permissions and Reprints

Abstract

The insertion allele of the angiotensin-converting enzyme (ACE) gene has been associated with endurance performance. Since a large portion of the variance seen in circulatory ACE levels is unaccounted for by the insertion/deletion polymorphism it is likely that the ACE phenotype would serve as a more informative marker in assessing elite endurance performance. The aim of this study was to correlate plasma ACE activity with performance of a homogenous population of South African-born Caucasian male triathletes. Plasma ACE activity was determined in 145 triathletes, representing the fastest and slowest subgroups who completed either the 2000 or 2001 South African Ironman Triathlon. There was a trend for lower mean plasma ACE activity in the fastest (28.85±8.60 mU/ml) when compared to the slowest finisher subgroup (31.65±8.75 mU/ml, P=0.055). There was a significant positive correlation between plasma ACE activity and overall finishing time within the participants who completed the event in under 15 h (r=0.192, P=0.029). There was also a positive correlation with cycle (r=0.195, P=0.034) and run (r=0.184, P=0.040) stages but not the swim stage (r=0.084, P=0.353). In conclusion, this is the first study to report a relationship between plasma ACE activity and endurance performance in humans.

Key words

angiotensin-converting enzyme - athlete - phenotype - RAAS - RAS
 

  • References

  • 1 Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med 1991; 117: 33-39
    PubMedGoogle Scholar
  • 2 Alvarez R, Terrados N, Ortolano R, Iglesias-Cubero G, Reguero JR, Batalla A, Cortina A, Fernandez-Garcia B, Rodriguez C, Braga S, Alvarez V, Coto E. Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol 2000; 82: 117-120
    CrossrefPubMedGoogle Scholar
  • 3 Brink M, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest 1996; 97: 2509-2516
    CrossrefPubMedGoogle Scholar
  • 4 Collins M. Preface. In: Collins M. (ed.). Genetics and Sports. Karger; 2009. 54. VII-VIII
    CrossrefGoogle Scholar
  • 5 Collins M, Xenophontos SL, Cariolou MA, Mokone GG, Hudson DE, Anastasiades L, Noakes TD. The ACE gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc 2004; 36: 1314-1320
    CrossrefPubMedGoogle Scholar
  • 6 Costa AM, Silva AJ, Garrido ND, Louro H, de Oliveira RJ, Breitenfeld L. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol 2009; 106: 785-790
    CrossrefPubMedGoogle Scholar
  • 7 Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290 (Pt 1) 33-40
    PubMedGoogle Scholar
  • 8 Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow L, Alhenc-Gelas F. Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies. J Hypertens 1996; 14: 719-727
    CrossrefPubMedGoogle Scholar
  • 9 Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92: 1387-1388
    CrossrefPubMedGoogle Scholar
  • 10 Davis GK, Millner RW, Roberts DH. Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/deletion polymorphism and left ventricular function. Eur J Heart Fail 2000; 2: 253-256
    CrossrefPubMedGoogle Scholar
  • 11 Dehnert C, Weymann J, Montgomery HE, Woods D, Maggiorini M, Scherrer U, Gibbs JS, Bartsch P. No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 2002; 34: 1928-1933
    CrossrefPubMedGoogle Scholar
  • 12 Friedland J, Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976; 66: 416-424
    PubMedGoogle Scholar
  • 13 Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, Trent RJ. Elite endurance athletes and the ACE I allele – the role of genes in athletic performance. Hum Genet 1998; 103: 48-50
    CrossrefPubMedGoogle Scholar
  • 14 Harriss DJ, Atkinson G. Update – ethical standards in sport and exercise science research. Int J Sports Med 2011; 32: 819-821
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266: 15377-15383
    PubMedGoogle Scholar
  • 16 Jalil JE, Ocaranza MP, Piddo AM, Jalil R. Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyl-leucine as substrate. J Lab Clin Med 1999; 133: 501-506
    CrossrefPubMedGoogle Scholar
  • 17 Jones A, Montgomery HE, Woods DR. Human performance: a role for the ACE genotype?. Exerc Sport Sci Rev 2002; 30: 184-190
    CrossrefPubMedGoogle Scholar
  • 18 Jones A, Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003; 35: 855-866
    CrossrefPubMedGoogle Scholar
  • 19 Kanazawa H, Otsuka T, Hirata K, Yoshikawa J. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 2002; 121: 697-701
    CrossrefPubMedGoogle Scholar
  • 20 Liu Y, Leri A, Li B, Wang X, Cheng W, Kajstura J, Anversa P. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ Res 1998; 82: 1145-1159
    CrossrefPubMedGoogle Scholar
  • 21 Montgomery H, Humphries S, Danilov S. Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease?. Eur Heart J 2002; 23: 1083-1086
    CrossrefPubMedGoogle Scholar
  • 22 Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE. Human gene for physical performance. Nature 1998; 393: 221-222
    CrossrefPubMedGoogle Scholar
  • 23 Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999; 87: 1313-1316
    PubMedGoogle Scholar
  • 24 Nazarov IB, Woods DR, Montgomery HE, Shneider OV, Kazakov VI, Tomilin NV, Rogozkin VA. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet 2001; 9: 797-801
    CrossrefPubMedGoogle Scholar
  • 25 Puthucheary Z, Skipworth JR, Rawal J, Loosemore M, Van SK, Montgomery HE. The ACE gene and human performance: 12 years on. Sports Med 2011; 41: 433-448
    CrossrefPubMedGoogle Scholar
  • 26 Raleigh SM. Epigenetic regulation of the ACE gene might be more relevant to endurance physiology than the I/D polymorphism. J Appl Physiol 2012; 112: 1082-1083
    CrossrefPubMedGoogle Scholar
  • 27 Rankinen T, Perusse L, Gagnon J, Chagnon YC, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. J Appl Physiol 2000; 88: 1029-1035
    PubMedGoogle Scholar
  • 28 Rankinen T, Wolfarth B, Simoneau JA, Maier-Lenz D, Rauramaa R, Rivera MA, Boulay MR, Chagnon YC, Perusse L, Keul J, Bouchard C. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 2000; 88: 1571-1575
    PubMedGoogle Scholar
  • 29 Rattigan S, Dora KA, Tong AC, Clark MG. Perfused skeletal muscle contraction and metabolism improved by angiotensin II-mediated vasoconstriction. Am J Physiol 1996; 271: E96-E103
    PubMedGoogle Scholar
  • 30 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346
    CrossrefPubMedGoogle Scholar
  • 31 Riviere G, Lienhard D, Andrieu T, Vieau D, Frey BM, Frey FJ. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 2011; 6: 478-489
    CrossrefPubMedGoogle Scholar
  • 32 Schwager SL, Carmona AK, Sturrock ED. A high-throughput fluorimetric assay for angiotensin I-converting enzyme. Nat Protoc 2006; 1: 1961-1964
    CrossrefPubMedGoogle Scholar
  • 33 Sharwood KA, Collins M, Goedecke JH, Wilson G, Noakes TD. Weight changes, medical complications, and performance during an Ironman triathlon. Br J Sports Med 2004; 38: 718-724
    CrossrefPubMedGoogle Scholar
  • 34 Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205
    PubMedGoogle Scholar
  • 35 Tsianos G, Sanders J, Dhamrait S, Humphries S, Grant S, Montgomery H. The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur J Appl Physiol 2004; 92: 360-362
    PubMedGoogle Scholar
  • 36 Williams AG, Day SH, Folland JP, Gohlke P, Dhamrait S, Montgomery HE. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc 2005; 37: 944-948
    PubMedGoogle Scholar
  • 37 Woods D, Hickman M, Jamshidi Y, Brull D, Vassiliou V, Jones A, Humphries S, Montgomery H. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 2001; 108: 230-232
    CrossrefPubMedGoogle Scholar
  • 38 Woods DR, World M, Rayson MP, Williams AG, Jubb M, Jamshidi Y, Hayward M, Mary DA, Humphries SE, Montgomery HE. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol 2002; 86: 240-244
    CrossrefPubMedGoogle Scholar
  • 39 Zill P, Baghai TC, Schule C, Born C, Frustuck C, Buttner A, Eisenmenger W, Varallo-Bedarida G, Rupprecht R, Moller HJ, Bondy B. DNA Methylation Analysis of the Angiotensin Converting Enzyme (ACE) Gene in Major Depression. PLoS One 2012; 7: e40479
    CrossrefPubMedGoogle Scholar